Weekly round-up: Optimum clients are rising to the top

/in

Xeltis successfully passes evaluation phase for €10million investment from European Innovation Council

Xeltis announces that it has successfully passed the evaluation phase of the 2025 European Innovation Council (‘EIC’) STEP Scale-Up call program, and is set to secure a €10 million equity investment from the EIC, subject to an award decision by the European Commission and the EIC Fund Investment Committee.

Infinitopes granted Phase I/IIa clinical trial application approval to evaluate precision vaccine targeting early-stage Oesophageal cancer

Infinitopes announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted Clinical Trial Application (CTA) approval for the first-in-human Phase I/IIa clinical trial of ITOP1, the company’s lead ‘off-the-shelf’ cancer vaccine designed to prevent the recurrence of oesophageal cancer.

Oxolife’s CEO Agnès Arbat receives prestigious EU Women Innovators Prize

Oxolife announced that Agnès Arbat, its Chief Executive Officer, has been awarded the prestigious EU Women Innovators Prize at the European Innovation Council (EIC) Summit on the 3rd of April 2025 in Brussels, Belgium. Oxolife is a female fertility biotech focused on increasing live birth rates by enhancing embryo implantation in women undergoing assisted reproductive technology (ART) fertility treatment.

👥 Optimum’s conference countdown

Save the date! Wednesday marked six months until Optimum’s 17th Annual Healthcare Investor Conference returns to The King’s Fund, London.

Join us on Thursday the 9th of October 2025 for a day of invaluable insights from thought leaders across the life sciences industry! Register your interest here.

🌟 Rising Leader winners

Fantastic to see Optimum clients Amir Hefni of Resolution Therapeutics and João Ribas of Novo Holdings Seed Investments named as In Vivo Rising Leaders 2025!

See the full list of nominees here.

📢 Hot topic

📆 Industry events

Key dates for your diary

  • 29 – 30th April is LSX World Congress in London, UK
  • 12 – 14th May is Bio€quity in Bruges, Belgium
  • 3rd July is ON Helix 2025 in Cambridge, UK
  • 9th October is Optimum’s 17th Annual Healthcare Investor Conference in London, UK

The Optimum team will be in attendance at all of the above events so please reach out to meet with us there.

That’s all folks!  To stay in the know – subscribe to Optimum’s weekly wrap-up today!